About Serge Pharma Private Limited
Data last updated:
Serge Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51909MP2017PTC043450. Its GSTIN is 23AAYCS7528Q1Z8 (Madhya Pradesh).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.61 Cr. It is led by directors Anju Soni and Vijay Laxmi Soni.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Indore, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.11 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹8.41 Cr (net margin 12%) and EBITDA of ₹17.4 Cr (EBITDA margin 24.8%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years.
Its group structure includes 1 subsidiary.
As per MCA filings, the company has satisfied charges of ₹10.54 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sergepharma.com.
Company details
Contact details
Serge Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its website is sergepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressOffice No. 201 J.V. Complex Part – A, Munshipal No. 2/13 Dr. Roshansingh Bhandari Marg, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Serge Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Serge Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Serge Pharma Private Limited, buy the company report.
Financials of Serge Pharma Private Limited
FY 2024 filings availableSerge Pharma Private Limited reported revenue of ₹70.11 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 67% over three years, including 31% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.4 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.41 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.8% | ||||
| Net Profit Margin | 12% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Serge Pharma Private Limited, buy the company report.
Board of directors of Serge Pharma Private Limited
Serge Pharma has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Soni Also directs: Neomi Polymers LLP, Arpan Events India Private Limited, Ekadanta Mineral Water Private Limited and 1 more | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
| Vijay Laxmi Soni Also directs: Neomi Polymers LLP, Riser Saffron Private Limited, Narayani Land and Buildings Private Limited and 5 more | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Serge Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chemsynth Drugs & Pharmaceuticals Private Limited | ₹70.25 Cr (FY 2024) | 29.0% | New Delhi, Delhi, India | |||
| Mishri Medipoint Private Limited | ₹70.23 Cr (FY 2025) | -20.0% | Chennai, Tamil Nadu, India | |||
| I B Pharma Private Limited | ₹70.17 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India | |||
| Serge Pharma Private Limitedthis company | ₹70.11 Cr (FY 2025) | ₹8.41 Cr | 12% | 31.0% | Indore, Madhya Pradesh, India | |
| Yatnesh Pharma Private Limited | ₹69.6 Cr (FY 2025) | 42.0% | New Delhi, Delhi, India | |||
| Astellas Pharma India Private Limited | ₹68.97 Cr (FY 2025) | 58.0% | Mumbai, Maharashtra, India | |||
| Radhashok Pharmachem Private Limited | ₹68.68 Cr (FY 2025) | -13.0% | Uttar Pradesh, India |
To see the full peer comparison of Serge Pharma Private Limited, buy the company report.
Auditor
Serge Pharma Private Limited is audited by Ayushi Katariya & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ayushi Katariya & Associates | FY 2023 | 437873 |
Shareholding
The shareholding of Serge Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Serge Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2024 | 100968598 | Others | ₹10.54 Cr | Satisfied |
To see the full charge records of Serge Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Serge Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Serge Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Serge Pharma has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Friends Unity Hospital & Research Centre Private Limited | U85110MP2010PTC024495 |
To see the full group structure of Serge Pharma Private Limited, buy the company report.
GST
Serge Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAYCS7528Q1Z8 | Madhya Pradesh | Active | 18 Nov 2020 |
To see the full GST registrations and return filing status of Serge Pharma Private Limited, buy the company report.
Recent activity
Serge Pharma Private Limited has 8 board changes on record since 2019: 2 appointments and 6 cessations. The latest: Sonu Pachori ceased to be Director on 30 Mar 2024.
1 earlier event is in the company report.
Frequently asked questions
Serge Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 June 2017 (9+ years old) and is registered under CIN U51909MP2017PTC043450.
Serge Pharma has 2 current directors:
- Anju Soni - Director
- Vijay Laxmi Soni - Director
The latest financial statements of Serge Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Serge Pharma is 23AAYCS7528Q1Z8, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Serge Pharma is U51909MP2017PTC043450. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Serge Pharma was incorporated on 01 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Serge Pharma by revenue are Chemsynth Drugs & Pharmaceuticals Private Limited, Mishri Medipoint Private Limited, I B Pharma Private Limited, Yatnesh Pharma Private Limited, Astellas Pharma India Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Sonu Pachori ceased to be Director on 30 Mar 2024. Anju Soni ceased to be Additional Director on 30 Sep 2022. Vijay Laxmi Soni ceased to be Additional Director on 30 Sep 2022. Serge Pharma has 8 board changes on record in total.
Serge Pharma can be reached through the website sergepharma.com. Its registered office is in Indore, Madhya Pradesh, India.
The registered office of Serge Pharma is at Office No. 201 J.V. Complex Part – A, Munshipal No. 213 Dr. Roshansingh Bhandari Marg, Indore, Madhya Pradesh, India – 452001.
Serge Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
